Bharat Biotech Archives - Organiser

April 18, 2024

No Result

View All Result

No Result

View All Result

No Result

View All Result

Bharat Biotech

Bharat Biotech forge strategic partnership with University of Sydney for vaccine research

Bharat Biotech forge strategic partnership with University of Sydney for vaccine research

On Republic Day, Bharat Biotech launches first India-made nasal Covid Vaccine

On Republic Day, Bharat Biotech launches first India-made nasal Covid Vaccine

Fake News: Govt rejects fake news reports that regulatory approval for Covaxin rushed due to Political Pressure

Fake News: Govt rejects fake news reports that regulatory approval for Covaxin rushed due to Political Pressure

Clinical phase III trials of the Bharat Biotech’s COVID-19 nasal vaccine completed

Clinical phase III trials of the Bharat Biotech’s COVID-19 nasal vaccine completed

Japan recognises India’s COVAXIN to facilitate travel between both countries

Covaxin safe for children aged 2-18 years, says Bharat Biotech

Bharat Biotech’s Covaxin Crosses Another Milestone, Gets Approval for Phase 2, 3 Trials on Children Aged 2-18 years

Covaxin booster shot enhances efficacy against Delta, Omicron variants of COVID-19: Study

Japan recognises India’s COVAXIN to facilitate travel between both countries

Germany to recognise Bharat Biotech’s COVAXIN for travel from June 1

CEPI partners with Bharat Biotech, University of Sydney, ExcellGene to develop ‘variant-proof’ COVID-19 vaccine

CEPI partners with Bharat Biotech, University of Sydney, ExcellGene to develop ‘variant-proof’ COVID-19 vaccine

Japan recognises India’s COVAXIN to facilitate travel between both countries

Bharat Biotech seeks DCGI’s permission to conduct Covaxin booster trials in the 2-18 age group

India’s expanding COVID-19 vaccination programme set to achieve new milestones

India’s expanding COVID-19 vaccination programme set to achieve new milestones

DCGI grants EUA to ZycovD COVID vaccine for a two-dose regimen for children above 12

DCGI grants EUA to ZycovD COVID vaccine for a two-dose regimen for children above 12

DCGI gives emergency use authorisation to Covaxin for the 6-12 age group

DCGI gives emergency use authorisation to Covaxin for the 6-12 age group

NDTV Broadcasts a 32-Minute Paid Content About Telangana Govt Disguised as News

NDTV Broadcasts a 32-Minute Paid Content About Telangana Govt Disguised as News

Japan recognises India’s COVAXIN to facilitate travel between both countries

Japan recognises India’s COVAXIN to facilitate travel between both countries

No Result

View All Result

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies